Bristol Myers Squibb BMY
NYSE BMY
$63.03 +0.20 (+0.32%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bristol Myers Squibb (BMY) Finished Goods (2010 - 2013)

Bristol Myers Squibb's (BMY) quarterly Finished Goods came in at $569.0 million in Q1 2013, up 13.57% year-over-year from $501.0 million in Q1 2012, and down 0.52% quarter-over-quarter from $572.0 million in Q4 2012.

Analysis

Bristol Myers Squibb (BMY) Finished Goods (2010 - 2013) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Finished Goods for 4 consecutive years, with $569.0 million the latest figure, recorded in Q1 2013.

  • On a quarterly basis, Finished Goods rose 13.57% year-over-year to $569.0 million in Q1 2013; TTM through Mar 2013 was $569.0 million, a 13.57% increase from a year earlier, with the FY2012 full-year figure at $572.0 million, up 19.67% from the prior year.
  • Finished Goods was $569.0 million for Q1 2013 at Bristol Myers Squibb, down from $572.0 million in the prior quarter.
  • Over five years, Finished Goods peaked at $572.0 million in Q4 2012 and troughed at $397.0 million in Q4 2010.
  • A 4-year average of $484.7 million and a median of $489.5 million in 2011 frame the typical range for Finished Goods.
  • Across the five-year window, Finished Goods increased 21.01% in 2012 and grew 13.57% in 2013, its largest moves.
  • Over 4 years, Finished Goods stood at $397.0 million in 2010, then grew by 20.4% to $478.0 million in 2011, then gained by 19.67% to $572.0 million in 2012, then retreated by 0.52% to $569.0 million in 2013.
  • The last three Finished Goods figures came in at $569.0 million (Q1 2013), $572.0 million (Q4 2012), and $533.0 million (Q3 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 569.00 Mn
Dec 31, 2012 572.00 Mn
Sep 30, 2012 533.00 Mn
Jun 30, 2012 503.00 Mn
Mar 31, 2012 501.00 Mn
Dec 31, 2011 478.00 Mn
Sep 30, 2011 443.00 Mn
Jun 30, 2011 437.00 Mn
Mar 31, 2011 414.00 Mn
Dec 31, 2010 397.00 Mn